Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: miralax + web + 0.25  Related to the article below (Last Update: 8/5/2008)

Schering-Plough Reports Financial Results for Second Quarter of 2008
PR Newswire (press release), NY - Jul 21, 2008
The increase was mainly due to higher sales of MIRALAX, launched in February 2007, partially offset by lower sales of OTC CLARITIN, due to the timing of ...SGP
Source: Google News

Patient Drug Information
RW Pelham, LC Nix, RE Chavira, MV Cleveland, P … - Aliment Pharmacol Ther, 2008 - ncbi.nlm.nih.gov
... not work well with NCBI's Web applications ... the administered dose ranged from 0.19
to 0.25%. ... Information. Polyethylene Glycol 3350 (MiraLax?) Polyethylene glycol ...

Symptoms and Their Treatment
F Assessment - Geriatric Medicine: An Evidence-based Approach, 2003 - books.google.com
... instruments may be found on the web at www ... mg tid-qid Hyoscyamine (Levsin)
0.125-0.25 sl q ... Polyethylene glycol solution (Golytely) or powder (Miralax) is often ...
-

Sources of Suffering in the Elderly
MT Carney, DE Meier - Springer
... assessment instruments may be found on the web at www ... mg tid-qid Hyoscyamine (Levsin)
0.125?0.25 sl q ... glycol solution (Golytely) or powder (Miralax) is often ...
-

Managing irritable bowel syndrome -
P Releases, CME Calendar, P Recruitment, C Center, … - mediwire.sma.org
President's Welcome. Mission/Vision. Leadership. Special Service Awards. Press Releases.
FAQ. Southern Medical Journal. CME Calendar. CME Online Library. ...

[PDF] Special Feature -
SA Council - Hospital Pharmacy - factsandcomparisons.com
... Complete USAN naming considerations can be found at the USAN Web site (http ... The patient
subsequently received digoxin 0.25 mg, because in Serbia the brand name ...

Selected Contribution: Hyperthermia-induced intestinal permeability and the role of oxidative and … -
GP Lambert, CV Gisolfi, DJ Berg, PL Moseley, LW … - Journal of Applied Physiology, 2002 - Am Physiological Soc
... Search for citing articles in: ISI Web of Science (8 ... The liquid diet contained a
laxative (Miralax; 4 g/500 ... oxygen, 5% carbon dioxide) M199 containing 0.25 mM FD ...

COMMONLY EMPLOYED DRUGS: DOSAGE RECOMMENDATIONS AND SIDE EFFECTS
Z Khaled - Essential Pediatric Gastroenterology, Hepatology, and …, 2005 - books.google.com
... Dosing (max 8 g per day) IV/IM, qid (dose based on ampicillin) Systemic fungal
infection: Test dose: 0.1 mg/kg per dose (max 1 mg) IV Initial dose: 0.25 mg/kg ...
-

[PDF] BASIC SYMPTOM CONTROL IN PAEDIATRIC PALLIATIVE CARE -
P CARE - act.org.uk
... phosphate enema. Step 6-if severely constipated use MiraLax or phosphate
enema or if you have time movicol (see table 6) Movicol ...

RAPE CRISIS SYNDROME
G PREVENTION, R FACTORS, I STABILIZATION, G … - The 5-minute Clinical Consult, 2007, 2006 - books.google.com
... Activity Full, when patient is able MEDICATION (DRUGS) ? Mineral oil ? Stool softeners ?
Lactulose ? Polyethylene glycol (Miralax, Glycolax) SURGERY ...
-

[DOC] BASIC SYMPTOM CONTROL IN PAEDIATRIC PALLIATIVE CARE -
DRSS JASSAL, S CONTRIBUTIONS, C BY - childhospice.org.uk
... phosphate enema. Step 6-if severely constipated use MiraLax or phosphate
enema or if you have time movicol (see table 6). Movicol ...

Source: Google Scholar

MiraLax safe for chronic constipation

Last Updated: 2007-07-24 15:49:57 -0400 (Reuters Health)

NEW YORK (Reuters Health) - MiraLax, which is currently available over-the-counter in the U.S, appears to remain safe and effective when use is extended for up to 6 months in patients with chronic constipation, researchers report in the American Journal of Gastroenterology.

This study extends the formal clinical investigation on the safety of the drug, also known as polyethylene glycol (PEG) 3350, and establishes that it is safe for long-term use, lead investigator Dr. Jack A. DiPalma told Reuters Health.

Compared with a placebo, MiraLax was effective and had an excellent safety profile," he said.

DiPalma of the University of South Alabama College of Medicine in Mobile and colleagues note that MiraLax is currently approved for the short-term treatment of occasional constipation.

To examine the effects of long-term use, the researchers studied 304 patients with chronic constipation. At the beginning of the study, constipation was confirmed over a period of 14 days. The patients were then randomly assigned to a single daily dose of MiraLax or placebo for 6 months.

Using relief of constipation of 50 percent or more of the time as a measure of effectiveness, the team established that at 6 months, 52 percent of PEG patients and 11 percent of placebo patients had successful responses. The results were similar in a subgroup of 75 elderly subjects.

Diarrhea, flatulence and nausea were more common in the MiraLax patients, but individually these conditions were not significantly worse than with placebo.

This study provides evidence that MiraLax is safe and effective for treating constipation in adult and elderly patients for up to 6 months, the investigators conclude.

SOURCE: American Journal of Gastroenterology, July 2007.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.